Mathai Mammen leaves position as JnJ Executive Vice President, Pharmaceuticals, RnD
New Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is identified.Dr. Mammen joined Johnson &...
New Brunswick: Johnson & Johnson has announced that Mathai Mammen, M.D., Ph.D., has decided to leave his position as Executive Vice President, Pharmaceuticals, R&D, and pursue other opportunities outside of the Company. William Hait, M.D., Ph.D., will serve as interim head of the Pharmaceutical R&D organization until new leadership is identified.
Dr. Mammen joined Johnson & Johnson in 2017 as Global Head of Janssen R&D. Previously, he was Senior Vice President, Cardiovascular diseases, Metabolic diseases, Immunology and Oncology at Merck.
"The Company thanks Dr. Mammen for his contributions in advancing Johnson & Johnson's industry-leading portfolio," the company stated.
Read also: Johnson and Johnson cancer drug sales help weather hit from stronger dollar
Founded in 1886, Johnson and Johnson is a Pharmaceutical industry company headquartered in New Brunswick, New Jersey, United States.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd